Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Peter A. Hevezi, Edward Tom, Keith Wilson, Peter Lambert, Gabriela Gutierrez-Reyes, David Kershenobich & Albert Zlotnik. (2011) Gene expression patterns in livers of Hispanic patients infected with hepatitis C virus. Autoimmunity 44:7, pages 532-542.
Read now
Read now
Articles from other publishers (12)
Viviana Figueroa Diaz, Mary Olson & Ira M. Jacobson. 2019. HCV: The Journey from Discovery to a Cure. HCV: The Journey from Discovery to a Cure
187
235
.
Sanhua Wei, Yingfeng Lei, Jie Yang, Xiaoyan Wang, Fang Shu, Xin Wei, Fang Lin, Bin Li, Ying Cui, Hai Zhang & Sanhua Wei. (2018) Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes. Vaccine 36:17, pages 2273-2281.
Crossref
Crossref
Aline C. Portela, Thalita G. Barros, Camilo H. da S. Lima, Luiza R.S. Dias, Pedro H.R. de A. Azevedo, Anna Sophia C.L. Dantas, Ronaldo Mohana-Borges, Gustavo T. Ventura, Sergio Pinheiro & Estela M.F. Muri. (2017) Isosorbide-based peptidomimetics as inhibitors of hepatitis C virus serine protease. Bioorganic & Medicinal Chemistry Letters 27:16, pages 3661-3665.
Crossref
Crossref
Wolf Peter Hofmann, Stefan Mauss, Thomas Lutz, Andreas Schober, Klaus Böker, Gero Moog, Axel Baumgarten, Heike Pfeiffer-Vornkahl, Ulrich Alshuth, Dietrich Hüppe, Heiner Wedemeyer, Michael P. Manns & Eckart Schott. (2015) Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study. PLOS ONE 10:7, pages e0134839.
Crossref
Crossref
Andrea De Luca, Claudia Bianco & Barbara Rossetti. (2014) Treatment of HCV infection with the novel NS3/4A protease inhibitors. Current Opinion in Pharmacology 18, pages 9-17.
Crossref
Crossref
Shuhei Nishiguchi, Hirayuki Enomoto, Nobuhiro Aizawa, Hiroki Nishikawa, Yukio Osaki, Yasuhiro Tsuda, Kazuhide Higuchi, Kazuichi Okazaki, Toshihito Seki, Soo Ryang Kim, Yasushi Hongo, Hisato Jyomura, Naoshi Nishida & Masatoshi Kudo. (2013) Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study. Journal of Gastroenterology 49:3, pages 492-501.
Crossref
Crossref
Kai-Henrik Peiffer & Christoph Sarrazin. (2013) The importance of HCV RNA measurement for tailoring treatment duration. Digestive and Liver Disease 45, pages S323-S331.
Crossref
Crossref
Michael E. Trigg. (2012) Emerging treatment advances in chronic hepatitis C. Community Oncology.
Crossref
Crossref
Pierre-Yves Bochud, Stéphanie Bibert, Zoltán Kutalik, Etienne Patin, Julien Guergnon, Bertrand Nalpas, Nicolas Goossens, Lorenz Kuske, Beat Müllhaupt, Tillman Gerlach, Markus H. Heim, Darius Moradpour, Andreas Cerny, Raffaele Malinverni, Stephan Regenass, Guenter Dollenmaier, Hans Hirsch, Gladys Martinetti, Meri Gorgiewski, Marc Bourlière, Thierry Poynard, Ioannis Theodorou, Laurent Abel, Stanislas Pol, Jean-François Dufour & Francesco Negro. (2012) IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes. Hepatology 55:2, pages 384-394.
Crossref
Crossref
Jama M. Darling, Stanley M. Lemon & Michael W. Fried. 2011. Schiff's Diseases of the Liver. Schiff's Diseases of the Liver
582
652
.
Geoffrey Dusheiko. 2011. Sherlock's Diseases of the Liver and Biliary System. Sherlock's Diseases of the Liver and Biliary System
406
426
.
Diwakar Davar, Ahmad Tarhini & John M. Kirkwood. (2011) Adjuvant Therapy: Melanoma. Journal of Skin Cancer 2011, pages 1-19.
Crossref
Crossref